De Beers cuts the low end to move it
De Beers took the sharpest action of the week on the rough market, slashing prices on certain smaller goods at its July sight, with reductions reportedly reaching 50% in some cases. For a producer that has spent two years defending price by cutting volume instead, a cut of that size on any category is a concession that the low end has to reprice to clear. The smaller goods are precisely where lab-grown supply has done the most damage, and the sight book finally reflected it. A sightholder does not walk away from a 50% concession on principle. The goods were sitting, and the only way to turn stones into cash was to let the price find the buyer rather than wait for the buyer to find the old price.
The volume data frames the decision. De Beers' second-quarter rough sales across its three sights totaled 7.1 million carats, down from 7.6 million carats in the same period a year earlier. Production, by contrast, ran the other way: for the first two quarters combined it rose 46% to 14.914 million carats. Producing more while selling less is the arithmetic that forces a price cut, and the July sight was where that pressure came due. A miner can hold that gap for a quarter or two on the balance sheet, carrying the unsold carats as inventory, but the wider the spread between what comes out of the ground and what clears the sight, the harder it becomes to keep pretending the list price is the market price.
The realized price tells the real story
The single figure that captures the year is the realized price. De Beers' consolidated average realized price fell 32% year over year in the first half to $105 per carat. That is a producer selling a materially cheaper mix at a materially lower price, and it sits at the center of the divestiture questions hanging over the business. The 32% is doing two jobs at once: part of it is the mix shifting toward smaller, cheaper goods as production climbed, and part of it is those goods themselves fetching less per carat. A dealer reading the tape should not treat $105 as a floor. It is an average across the book, which means the bottom of that book is already selling for a good deal less. Our industry desk tracks how that pressure fits the wider retail picture, because the rough weakness and the retail jewelry strength are, oddly, coexisting this quarter.
That coexistence is the part the trade has to hold in its head. Branded jewelry demand at the maisons is running strong; LVMH's jewelry division led its group at 9% organic growth in the first half, driven by Tiffany and Bvlgari, while the rough that feeds the broader natural pipeline is repricing lower. The two are not contradictory: the strength is in finished, branded goods, and the weakness is in the commodity small stones that lab-grown now substitutes for directly. A Tiffany buyer is not shopping loose melee by the carat, and the melee market is not selling stories. They are two different businesses that happen to share a raw material.
The lab-grown spread keeps widening
The lab-grown numbers explain the pressure on the low end better than any sight report. A one-carat lab-grown diamond now carries a fair market price of $770, and the lowest-priced mainstream-quality one-carat lab stone is available for $595. Per-carat averages sit at $564 at one carat, down 2.59% year over year in 2026, so lab prices are still drifting lower even at these levels. When the manufactured product keeps falling on its own, the natural low end cannot hold a premium out of proportion to it, and the sight cut is the pipeline admitting as much.
Set that against natural. A natural one-carat diamond averages roughly $4,200 to $4,600 at retail, which puts lab-grown stones 70 to 90 percent below natural of comparable size and grade. A gap that wide means the two products no longer compete for the same buyer at the same moment. They have split into separate categories with separate customers. The lab stone is a fashion price point measured in hundreds. The natural solitaire is a considered purchase measured in thousands. Once a spread reaches that width it stops being a discount and becomes a category line. Our week wrap covers how that split played across the rest of the trade.
What retailers should read into it
For a retail buyer the practical takeaway is inventory discipline. The De Beers cut on smaller goods will work its way into melee and side-stone pricing over the next few months, which is a reason to buy those categories short and often rather than deep. Carrying a deep melee position while the underlying rough is still repricing lower means writing down goods that were bought at last quarter's number. On the natural solitaire, the $4,200 to $4,600 band has held even as rough repriced, which says the finished-goods margin is intact where the stone carries a story the lab product cannot. The open question is how far the $105 realized price can fall before it forces a structural change in how the natural low end is mined and sold at all.
Comments 0
No comments yet. Be the first to share your thoughts.